FactSheets

New Mini Review: Effectiveness of Protein Structure Based Design (SBDD) in Drug Discovery: A Style and Approach that has proven to be Very Successful

An example of clinical candidate from our SBDD expertise: Telaprevir(VX-950)-a mega HCV drug approved by FDA in May, 23rd 2011

  • Telaprevir currently is on phase III clinical trial to test its luck for a blockbuster drug...more
  • Telaprevir added value to its company and will be a multi-billion dollar drug after approved...learn more
  • Telaprevir-a powerful anti-HCV drug
  • Telaprevir-the most Competitive drug candidate among clinical trials for HCV treatment

    • The Rational Drug Design services through Rebexsess Discovery Chemistry has helped clients in following aspects:

  • Delivered the results for proof of concept-successfully raised funding for startup companies
  • Made breakthrough in the projects-increased stock value for client companies
  • Revitalized stalled project-added values to a client company

    • The result from POC service has provided a successful service model for Startup fund raising, which convincingly proved that Rebexsess' service is truly cost-effective and time efficient. In the current biotech financial climate, seed funding has become very limited and challenged for raising VC funds. Therefore, the Medicinal Chemistry service model at Rebexsess is ideal for the companies that intend to get preliminary chemistry results for the fund raising with a limited budget without internal medicinal chemistry group.

    Rebexsess has also provided external insights and expertise to the internal groups of well-established biotech/pharmaceutical clients revitalizing their scientific creativity and moving their project forward.